beta
IA Trial Radar
Un estudio coincide con los criterios de filtro
Vista de tarjeta
Volver a la búsqueda

Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform 130 Personalizado Prevención

Completado
Los detalles del ensayo clínico están disponibles principalmente en inglés. ¡Sin embargo, IA Trial Radar puede ayudar! Simplemente haga clic en 'Explicar el estudio' para ver y discutir la información del estudio en el idioma que haya seleccionado.
El ensayo clínico NCT04369833 fue un estudio observacional para Pre-diabetes, Trastornos del Metabolismo de la Glucosa, Diabetes mellitus. Su estado actual es: completado. El estudio se inició el 11 de mayo de 2020, con el objetivo de reclutar a 130 participantes. Dirigido por Pusan National University Hospital, la fecha de finalización prevista fue el 30 de septiembre de 2020. Los datos se actualizaron por última vez en ClinicalTrials.gov el 9 de mayo de 2022.
Resumen
The purpose of this study is to collect a variety of clinical data and blood glucose changes using a continuous glucose monitoring device for high-risk diabetes patients (prediabetes) in order to develop a personalized diabetes prevention and management platform based on artificial intelligence model using mathematical analysis.
Descripción detallada
After being informed about the study and potential risks, all patients giving written informed consent wear a continuous glucose monitoring device ("iPro2" professional continuous glucose monitoring, MedtronicⓇ, California, USA) and smart band ("Fitbit Inspire HR", FitbitⓇ, California, USA) for 1 week.

During this period, all patients are tested oral glucose tolerance test and take a standard diet (calorie calculate...

Mostrar más
Título oficial

Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform Based on Artificial Intelligence Model Using Mathematical Analysis

Condiciones médicas
Pre-diabetesTrastornos del Metabolismo de la GlucosaDiabetes mellitus
Publicaciones
Artículos científicos y trabajos de investigación publicados sobre este estudio clínico:
Otros ID del estudio
  • H-2003-033-088
Número del NCT
NCT04369833
Inicio del estudio (real)
2020-05-11
Última actualización
2022-05-09
Fecha de finalización (estimada)
2020-09-30
Inscripción (prevista)
130
Tipo de estudio
Observacional
Estado general
Completado
Brazos / Intervenciones
Grupo de participantesIntervención/Tratamiento
continuous glucose monitoring group
all participants wearing a continuous glucose monitoring device
continuous glucose monitoring system
wearing continuous glucose monitoring device (iPro2 professional continuous glucose monitoring, MedtronicⓇ, California, USA)
Resultado primario
Medida de resultadoDescripción de la medidaPeriodo de tiempo
Number of Participants With Insulin Resistance
the prevalence of insulin resistance in participants was measured. Insulin resistance was calculated by HOMA-IR(homeostatic model assessment of insulin resistance), QUICKI (quantitative insulin sensitivity check index) and Matsuda index
1 week
Criterios de elegibilidad

Criterios de edad
Adulto, Adulto mayor
Edad mínima
18 Years
Criterios de sexo
Todos

  • Above 18 years old.

  • Prediabetes

    1. Fasting plasma glucose : 100~125mg/dL, fasting is defined as no caloric intake for at least 8 hours.

      OR

    2. 2-hour plasma glucose during 75g oral glucose tolerance test : 140 ~ 199mg/dL

      OR

    3. Glycated hemoglobin(HbA1c) : 5.7~6.4% (39-47mmol/mol)

  • with a history of newly diagnosed and treated cancer within the last 5 years
  • with a history of hospitalization for active disease within the last 3 months
  • with a history of severe cardiovascular disease within the last 3 months
  • with a history of steroid treatment in the last 3 months
  • people who have had major surgery planned within the last 3 months or who have had surgery within 3 months
  • people who are pregnant or have been in the last 3 months after giving birth
Pusan National University Hospital logoPusan National University Hospital
No hay datos de contacto.
1 Centros del estudio en 1 países
Pusan national university hospital, Busan, 49241, South Korea